Focusing on You: New Treatment for Patients with Atrial Fibrillation

Reading Time: 1 minute

LEAF Clinical Trial Opens for Patients with Afib

Dr. Jeffrey Goldberger, chief of the Cardiovascular Division at UHealth, the University of Miami Health System, discusses the LEAF clinical trial, designed to look at the effectiveness of the drug Liraglutide in the treatment of atrial fibrillation. Click here for the full story on the LEAF trial.